Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Synergy Rx is recalling all lots of HCG products nationwide due to a lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling Fluorouracil creams because of a lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling Cantharidin 0.7% Solution and Cantharidan/Podophyllum Solution due to lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling ACNE SOLUTION, a prescription topical medication, due to a lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling all lots of CLEAR 2 (Benzoyl Peroxide 2.5%, Clindamycin 1.2%) because the product lacks assurance of sterility and has CGMP deviations.
Synergy Rx is recalling Lactic Acid Solution in all strengths due to a lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling various lidocaine cream and ointment products nationwide due to a lack of assurance of sterility and CGMP deviations.
Synergy Rx is recalling Supreme Cream due to a lack of assurance of sterility and CGMP deviations.
McKesson Packaging Services is recalling 6,717 cartons of 81 mg Aspirin Chewable Tablets because foreign material was found in the bulk inventory.
Mylan Pharmaceuticals is recalling Mirtazapine tablets because bottles may contain foreign Glipizide 10 mg tablets. Consumers should stop using the product and contact their pharmacist.
Endo Pharmaceuticals is recalling 5,086 cartridges of EDEX (alprostadil) 10mcg injection due to a defective container that compromises sterility assurance.
Mylan Institutional is recalling Mirtazapine 45 mg tablets because they may contain foreign Glipizide 10 mg tablets.
Jeffreys Drug Store is recalling compounded Domperidone capsules 10 mg because the product was marketed without an approved NDA/ANDA, meaning safety and efficacy have not been established.
United Exchange Corporation is recalling 46,080 bottles of Eye Wash due to direct evidence of non-sterility contamination in two lots.
Pacific Medical Solutions is recalling Nano PNC Water because it was marketed without FDA approval and tested positive for the bacterium variovorax paradoxus.
Mylan Pharmaceuticals is recalling 1,338 bottles of Glipizide 5 mg Extended-Release Tablets because they may contain 10 mg tablets.
United Exchange Corporation is recalling 112,320 bottles of Eye Irrigating Solution because the product lacks assurance of sterility.
AbbVie is recalling Duopa (carbidopa and levodopa) cassettes because stability testing showed the drug may settle near the end of its shelf life.
United Exchange Corporation is recalling 77,184 bottles of Eye Wash because the product lacks assurance of sterility. The recall covers specific lots distributed nationwide, in Puerto Rico, and in Guyana.
United Exchange Corporation is recalling 190,710 bottles of Eye Wash due to a lack of assurance of sterility. The product was distributed nationwide, in Puerto Rico, and in Guyana.
G&W Laboratories is recalling Indocin suppositories due to out-of-specification impurity results found during stability testing.
RemedyRepack Inc. is recalling Glipizide 2.5 mg ER tablets because they failed to meet dissolution specifications. The product was distributed to a customer in Florida.
Apotex Inc. is recalling 19,584 bottles of Cyclosporine Capsules, USP, 100 mg, because the product failed impurity specifications.
Moore's Compounding Pharmacy is recalling Levothyroxine Sodium/Liothyronine SR capsules due to superpotent and subpotent potency failures.
Hospira is recalling 578,784 bags of Metronidazole Injection due to a customer report of a leaking bag, which compromises sterility assurance.